Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

Nvidia, the computer chip giant, continues its deep dive into expanding artificial intelligence technology in the medtech and cancer research arenas, this time with diagnostics maker Droplet ...

Integrative high-throughput studies identify novel targets and drugs for advanced prostate cancer treatment Prostate cancer, a prevalent malignancy ...

Conventional PCR systems require users to set a predetermined number of cycles based on assay- and sample-specific factors. When performing single-cell sequencing experiments, this requires knowledge ...

Lattice Semiconductor ( LSCC +6.01%) reported sequential and year-over-year acceleration in revenue and earnings, citing ...

Oxford Nanopore Technologies plc ( ONTTF) Q4 2025 Earnings Call March 2, 2026 5:45 AM EST Good morning, everyone, and thank you for joining us today. Before we move into the 2025 results presentation, ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 3:10 PM ESTCompany ParticipantsJacob Thaysen - CEO, Interim Chief ...

Cerro Bayo is being advanced under an option agreement with Daura Gold, which can earn up to an 80% interest through staged cash payments and exploration expenditures. All drilling activities are ...

Fresnillo's full-year 2025 results are due on 3 March 2026. Learn what investors should expect including silver and gold production, costs and dividend prospects.

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

March 2026 Results.) Fresnillo full-year earnings forecast ahead of 3 March 2026 results ​Fresnillo - the world's largest primary silver producer and a leading gold miner - is poised to release its 20 ...